NR1H4 and metabolic dysfunction-associated steatotic liver disease: Dysbiosis leads to the development and progression of MASLD through gut-liver axis that is regulated by bile acids (BA) receptors [33], such as farnesoid X receptor (FXR) and Takeda G-coupled protein receptor 5 (TGR5).